Hodroj MH - Search Results

1

Thalassemia and malignancies: Updates from the literature.

Hodroj MH, Taher A. Hodroj MH, et al. Ann N Y Acad Sci. 2023 Nov;1529(1):14-20. doi: 10.1111/nyas.15061. Epub 2023 Sep 7. Ann N Y Acad Sci. 2023. PMID: 37676814 Review.

2

Beta-thalassemia: is cure still a dream?

Hodroj MH, Akiki N, Bou-Fakhredin R, Taher AT. Hodroj MH, et al. Minerva Med. 2023 Dec;114(6):850-860. doi: 10.23736/S0026-4806.23.08501-4. Epub 2023 Aug 3. Minerva Med. 2023. PMID: 37534831 Review.

3

Thalassemia and malignancy: An emerging concern?

Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, Noureldine HA, Noureldine MHA, Taher AT. Hodroj MH, et al. Blood Rev. 2019 Sep;37:100585. doi: 10.1016/j.blre.2019.06.002. Epub 2019 Jun 22. Blood Rev. 2019. PMID: 31253373 Review.

4

Hematological malignancies in connective tissue diseases.

Noureldine HA, Nour-Eldine W, Hodroj MH, Noureldine MHA, Taher A, Uthman I. Noureldine HA, et al. Among authors: hodroj mh. Lupus. 2020 Mar;29(3):225-235. doi: 10.1177/0961203319899986. Epub 2020 Jan 14. Lupus. 2020. PMID: 31933408 Review.

5

COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals.

Noun P, Ibrahim A, Hodroj MH, Bou-Fakhredin R, Taher AT. Noun P, et al. Among authors: hodroj mh. Expert Rev Hematol. 2020 Oct;13(10):1081-1092. doi: 10.1080/17474086.2020.1819785. Epub 2020 Sep 15. Expert Rev Hematol. 2020. PMID: 32931348 Review.

6

COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.

Al Mahmasani L, Hodroj MH, Finianos A, Taher A. Al Mahmasani L, et al. Among authors: hodroj mh. Ann Hematol. 2021 May;100(5):1115-1122. doi: 10.1007/s00277-021-04441-y. Epub 2021 Feb 1. Ann Hematol. 2021. PMID: 33527161 Free PMC article. Review.

7

Clinical burden of hemophilia in older adults: Beyond bleeding risk.

Hodroj MH, El Hasbani G, Al-Shamsi HO, Samaha H, Musallam KM, Taher AT. Hodroj MH, et al. Blood Rev. 2022 May;53:100912. doi: 10.1016/j.blre.2021.100912. Epub 2021 Dec 5. Blood Rev. 2022. PMID: 34887154 Review.

8

Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report.

Fawaz H, Hodroj MH, Tarhini H, Trad CO, Taher A. Fawaz H, et al. Among authors: hodroj mh. Ann Hematol. 2023 Nov;102(11):3271-3273. doi: 10.1007/s00277-023-05370-8. Epub 2023 Jul 22. Ann Hematol. 2023. PMID: 37481472 No abstract available.

9

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).

Assi HI, Zerdan MB, Hodroj M, Khoury M, Naji NS, Amhaz G, Zeidane RA, El Karak F. Assi HI, et al. Oncotarget. 2023 May 26;14:517-525. doi: 10.18632/oncotarget.28444. Oncotarget. 2023. PMID: 37235814 Free PMC article.

10

Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia.

Hodroj MH, Abou Dalle I, Moukalled N, El Cheikh J, Mohty M, Bazarbachi A. Hodroj MH, et al. Front Immunol. 2023 Jun 8;14:1191912. doi: 10.3389/fimmu.2023.1191912. eCollection 2023. Front Immunol. 2023. PMID: 37359547 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page